Company Filing History:
Years Active: 2019
Title: Wei Yu - Innovator in Cancer Treatment
Introduction
Wei Yu is a prominent inventor based in South San Francisco, CA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on utilizing cancer biomarkers to improve patient outcomes.
Latest Patents
Wei Yu holds a patent titled "Cancer treatment with c-met antagonists and correlation of the latter with HGF expression." This invention addresses the role of HGF as a biomarker for patient selection and prognosis in cancer. It also encompasses methods of therapeutic treatment, articles of manufacture, diagnostic kits, and methods for detection related to cancer biomarkers.
Career Highlights
Wei Yu is associated with Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. His work at Genentech has allowed him to contribute to groundbreaking advancements in cancer treatment.
Collaborations
Wei Yu has collaborated with notable colleagues, including David Shames and Hartmut Koeppen. These collaborations have further enhanced his research and development efforts in the field of cancer treatment.
Conclusion
Wei Yu's contributions to cancer treatment through his innovative patent and work at Genentech highlight his commitment to improving patient care. His research continues to pave the way for advancements in cancer therapies.